<DOC>
	<DOC>NCT02132728</DOC>
	<brief_summary>This study aims to evaluate the effects of enterolignanas of flaxseed on nutritional and inflammatory indicators in male workers of a food industry.</brief_summary>
	<brief_title>Impact of Flaxseed on the Syndrome Metabolic Inflammation</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Work in the manufacturing company in the city of ItuSP. Have at least three of the following cardiovascular risk factors: waist circumference ≥ 90 cm; overweight or obese characterized by BMI ≥ 25 kg/m²; fasting total cholesterol ≥ 200 mg/dL, LDL cholesterol ≥ 130 mg/dL and HDLcholesterol &lt; 40 mg/dL, triglycerides ≥ 150 mg/dL; glycemia ≥100 mg/dL; and hypertension characterized by systolic blood pressure ≥140 mm/Hg and/or diastolic blood pressure ≥ 90 mm/Hg. Female gender</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>flaxseed</keyword>
	<keyword>lignans</keyword>
	<keyword>inflammation</keyword>
	<keyword>Nutrition</keyword>
	<keyword>enterolactone</keyword>
	<keyword>enterodiol</keyword>
</DOC>